Concepedia

Author

Olivier Godeaux

GlaxoSmithKline (Belgium)

Also Known As

O. Godeaux, Olivier Godeaux, Olivier O. Godeaux

35

Publications

3.8K

Citations

18

H-Index

7

Concepts

All Affiliations

GlaxoSmithKline (Belgium)GlaxoSmithKline (United States)Walter Reed Army Institute of ResearchUniversidade Federal de São Paulo
OG

About

Olivier Godeaux is an author at GlaxoSmithKline (Belgium) specializing in human papillomavirus vaccines, virology, and vaccination.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

152

2

Immunology

1

1

152

3

Vaccine Development

1

1

152

4

Human Papillomavirus Vaccines

1

1

152

5

Vaccination

1

1

152

Olivier Godeaux

×

20

Publications

3.8K

Citations

18

H-Index

YearCitations

Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

Himal Lal, Anthony L. Cunningham, Olivier Godeaux,

New England Journal of Medicine

2015

1.4K

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

Anthony L. Cunningham, Himal Lal, Martina Kovac,

New England Journal of Medicine

2016

1K

A Field Trial to Assess a Blood-Stage Malaria Vaccine

Mahamadou A. Théra, Ogobara K. Doumbo, Drissa Coulibaly,

New England Journal of Medicine

2011

358

Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older

Anthony L. Cunningham, Thomas C. Heineman, Himal Lal,

The Journal of Infectious Diseases

2018

185

Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine in Healthy Boys Aged 10–18 Years

Tiina Petäjä, Heli Keränen, Tiina Karppa,

Journal of Adolescent Health

2008

152

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: A randomized trial

Peter Vink, Ignacio Delgado Mingorance, C. Maximiano Alonso,

Cancer

2019

112

Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine With an Adenovirus 26 Vector Encoding Prefusion F (Ad26.RSV.preF) in Adults Aged ≥60 Years

Kristi L. Williams, Arangassery Rosemary Bastian, Robert Feldman,

The Journal of Infectious Diseases

2020

109

Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older

Tino F. Schwarz, Naresh Aggarwal, Beate Moeckesch,

The Journal of Infectious Diseases

2017

76

Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials

Marta López‐Fauqued, Laura Cámpora, Frédérique Delannois,

Vaccine

2019

61

Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children: Results of a Phase 1 Randomized Controlled Trial

Mahamadou A. Théra, Ogobara K. Doumbo, Drissa Coulibaly,

PLoS ONE

2010

56

Page 1